1. Home
  2. Rapid Ag Test
  3. Avacta® AffiDX® SARS-CoV-2 Antigen Lateral Flow Test

Avacta® AffiDX® SARS-CoV-2 Antigen Lateral Flow Test


25 Tests

SKU: BSV-COV-11711125

Accurate detection, comfortable sample collection and interpretation of results in just 20 minutes

The AffiDX® SARS-CoV-2 Antigen Lateral Flow Test is an ideal solution for point-of-care and decentralised testing to identify individuals with higher viral loads of SARS-CoV-2 that increase the likelihood of transmitting the infection to others. Wholly developed and manufactured in the UK utilising accurate, flexible Affimer® technology, and validated against emerging variants of SARS-CoV-2.

Intended Use:

The Avacta AffiDX® SARS-CoV-2 Antigen Lateral Flow Test is a qualitative in vitro diagnostic (IVD) test to detect SARS-CoV-2 antigen in human anterior nasal swabs. The test is intended for professional use only. Assay validation and clinical evaluations of the test were conducted in the UK and EU using routine prospective samples in general population and healthcare settings.

Key Benefits

  • Patient-friendly – Anterior nares (nasal) swabs samples for more comfortable collection
  • Reliable Results – Accurate for identifying individuals likely to be infectious: 98% sensitivity and 99% specificity
  • Monitored Against Variants – Routine monitoring of emerging variants to ensure continued diagnostic accuracy
  • U.K. Made – Developed and manufactured in the United Kingdom
  • Accessible – Suitable for Point of Care settings and allows for decentralised testing
  • Rapid & Simple – Easy to use, simple work-flow, results in only 20 minutes
  • Convenient – Contains everything needed to run a test with no additional equipment required
  • Practical – Room temperature storage, transportation and testing

Clinical Evaluation:

Ct = Ct Value = the number of amplification cycles needed for a virus to be detected by PCR; the lower the Ct, the higher the viral load in the sample.